Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport
2001 ◽
Vol 18
(6)
◽
pp. 509-513
◽
2014 ◽
Vol 235
(2)
◽
pp. 415-417
◽
2011 ◽
Vol 3
(1)
◽
pp. 86
2008 ◽
Vol 15
(1)
◽
pp. 20-25
◽
2010 ◽
Vol 43
(13-14)
◽
pp. 1079-1084
◽
2012 ◽
Vol 4
(1)
◽
pp. 95-96
2008 ◽
Vol 2
(4)
◽
pp. 283
◽
Keyword(s):
2000 ◽
Vol 52
(4)
◽
pp. 403-411
◽